A Prospective, Open-Label Study of Paliperidone ER in Adolescents and Young Adults With Autism.
Phase of Trial: Phase III
Latest Information Update: 22 May 2017
At a glance
- Drugs Paliperidone (Primary)
- Indications Autistic disorder
- Focus Registrational; Therapeutic Use
- 20 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Sep 2009 Planned end date changed from 1 Aug 2009 to 1 Sep 2010 as reported by ClinicalTrials.gov.
- 20 Dec 2007 Status changed from initiated to recruiting.